STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming
Zhaowei Chu,Lei Gu,Yeguang Hu,Xiaoyang Zhang,Man Li,Jiajia Chen,Da Teng,Man Huang,Che-Hung Shen,Li Cai,Toshimi Yoshida,Yifeng Qi,Zhixin Niu,Austin Feng,Songmei Geng,Dennie T. Frederick,Emma Specht,Adriano Piris,Ryan J. Sullivan,Keith T. Flaherty,Genevieve M. Boland,Katia Georgopoulos,David Liu,Yang Shi,Bin Zheng
DOI: https://doi.org/10.1038/s41467-022-29541-9
IF: 16.6
2022-04-06
Nature Communications
Abstract:Abstract The cohesin complex participates in the organization of 3D genome through generating and maintaining DNA loops. Stromal antigen 2 (STAG2), a core subunit of the cohesin complex, is frequently mutated in various cancers. However, the impact of STAG2 inactivation on 3D genome organization, especially the long-range enhancer-promoter contacts and subsequent gene expression control in cancer, remains poorly understood. Here we show that depletion of STAG2 in melanoma cells leads to expansion of topologically associating domains (TADs) and enhances the formation of acetylated histone H3 lysine 27 (H3K27ac)-associated DNA loops at sites where binding of STAG2 is switched to its paralog STAG1. We further identify Interferon Regulatory Factor 9 (IRF9) as a major direct target of STAG2 in melanoma cells via integrated RNA-seq, STAG2 ChIP-seq and H3K27ac HiChIP analyses. We demonstrate that loss of STAG2 activates IRF9 through modulating the 3D genome organization, which in turn enhances type I interferon signaling and increases the expression of PD-L1. Our findings not only establish a previously unknown role of the STAG2 to STAG1 switch in 3D genome organization, but also reveal a functional link between STAG2 and interferon signaling in cancer cells, which may enhance the immune evasion potential in STAG2-mutant cancer.
multidisciplinary sciences